China-based ophthalmic medical services provider Aier Eye Hospital Group Co., Ltd (SHE: 300015) is set to conduct an initial public offering (IPO) of 133 million shares at RMB 26.49 (USD 3.70) per share on the Shenzhen Stock Exchange’s ChiNext board. The offering is expected to raise RMB 3.54 billion (USD 488 million). The proceeds will be used to support the company’s expansion and development in the ophthalmic services sector.
First Half Performance
In the first half of this year, Aier Eye Hospital Group reported a lukewarm performance. The company generated RMB 8.1 billion (USD 1.1 billion) in revenue, up 10.34% year-on-year (YOY), and RMB 1.29 billion (USD 180.1 million) in net profits, up 15.73% YOY. Despite the modest growth, the company has shown resilience in the face of market challenges.
Expansion and Acquisitions
As of June 30, 2022, Aier Eye Hospital Group owns 187 domestic hospitals and 132 clinics. During the first half of this year, the company acquired 16 eye hospitals and clinics, further expanding its presence in the ophthalmic services market. The IPO is expected to provide additional capital to support ongoing expansion and strategic initiatives.
Future Outlook
The planned IPO underscores Aier Eye Hospital Group’s commitment to strengthening its position in the ophthalmic services sector. By leveraging the funds raised, the company aims to enhance its service capabilities, expand its network of hospitals and clinics, and improve patient outcomes.-Fineline Info & Tech
